Positive results presented of the VISION trial
During the virtual ASCO 2021 meeting, the highly anticipated results of the phase III study with radioligand therapy 177Lu-PSMA-617 in patients with advanced prostate cancer (VISION trial) were presented.
BELNUC Technology Partner 2021
BELNUC is honored to present its technology partner for 2021: Advanced Accelerator Applications (AAA). AAA is an innovative medicines company focused on the development of products for targeted radioligand therapy and precision radioligand imaging. With the commitment of AAA, BELNUC is able to support its online educational activities and maintain its digital infrastructure.
Odisee survey on the use of artificial intelligence
The professional bachelor program in medical imaging and radiotherapy of Odisee wishes, by means of a short survey, to examine to what extent artificial intelligence is already present in the field and how the program should adapt the future curriculum to this. The opinion of the nuclear medicine physician is very important to us. It will take just 5 minutes to complete the questionnaire.
Click on this link https://odisee.qualtrics.com/jfe/form/SV_cTk1pp4lqffipO6 to complete the questionnaire.
Completion is possible until 20/4. Thank you in advance for your contribution.
Open call tech board members
The BELNUC Tech Board is looking for enthusiastic new members to join their team and help shape the future of technologist’s representation within our society.
Do you want to contribute to improving the science and practice of nuclear medicine? Send in your application today using the form below!
European Course on Lymphatic Imagings In the Management of (Lymph)Edemas and Benign Lymphatic Pathologies – COURSE 2021 GOES VIRTUAL!
European Course on Lymphatic Imagings In the Management of (Lymph)Edemas and Benign Lymphatic Pathologies
COURSE 2021 GOES VIRTUAL!
Dear colleagues,
Many things have changed since COVID-19 entered our lives, but one stubborn fact has remained the same: large, in-person gatherings are a public health risk. While we are all hoping for a breakthrough against the pandemic soon, public health officials are telling us it could be another year or more before we can safely go back to in-person meetings.
So today, I wish to inform you that the course will be hold entirely online.
Course goals:
In a context in which the quality requirement in health care is becoming more and more prevalent (with, for instance, a requirement for a minimum number of patients treated for recognition in certain areas, “health care providers quality law” approved and to enter in Belgium into practice in 2021, …), it therefore seems justified if not necessary to introduce training-teaching the different imagings of the lymphatic system (Lymphoscintigraphies, Nuclear Magnetic Resonance lymphangiographies, Lympho-Fluoroscopies and others) used in the management of (lymh)edemas (and other benign lymphatic pathologies), not only theoretical but also and above all practical (diagnoses integrated in the clinic and with well understood therapeutic purposes) with expert guidance, ultimately leading to the creation of network (national and European) of exchanges of experience which also advances the body of knowledge of these lymphatic pathologies.
With delivery of Certificate of Basic and Practical Competences in Lymphatic Imaging
By the ULB Faculty of Medicine.
The certificate of “Basic” Competences in Lymphatic Imagings will also be issued by the BeSL and ESL (at the end of the 1rst course and the certificate of “Practical” Competences in Lymphatic Imagings during the ESL(/ISL) meeting in Athens (21-24/09/2021) after evaluation of the participants’ “on site” practices, their presentation of one personal work and after one last exam.
Training will include: – A contextualization of these imagings to the useful anatomical and physio-pathological data of the lymphatic system, to the clinical data of the benign pathologies for which they are prescribed, to the expectations and uses of the prescribers, – Development of methodologies in application, – Making recommendations on their achievements (from tracers to reports), – During two days, the presentation of cases-series of these imagings in their clinical context with their therapeutic implications, – Meeting of European and international experts on these topics, – The “live” case discussion with various Belgian practitioners, – Participation in the annual scientific meeting of the BeSL, an opportunity to meet the actors of the “land-region”.
Target audiences:
1) Doctors specializing in imagery (“nuclearists” and radiologists) facing these examinations as part of their specialty
2) Physicians and surgeons users of these images
3) General doctors and specialists (angeologists, phlebologists, cardio-vascular doctors, oncologists, …) prescribers of these imageries
4) Physiotherapists
People who wish to register for this course are invited to send to Prof P Bourgeois (pierre.bourgeois@erasme.ulb.ac.be):
- a short CV with (important) the description of their activities,
- a letter of intent,
- a short letter explaining their interest regarding Lymphology (and the investigations of lymphatic pathologies) and (important) their expectations for this course.
Recognized full time practitioner: | 1500 Euros |
Trainee: | 950 Euros |
TO REGISTER, USE THE LINK: https://www.ulb.be/fr/programme/fc-724#admission
550 Euros will be reimbursed to the first ten non-Belgian registrants (registered before the 1/04/2021) by the Foundation For Lymphology upon/after receipt of their final certificate (during the meeting of the International Society of Lymphology in Athens).
European Course on Lymphatic Imagings In the Management of (Lymph)Edemas and Benign Lymphatic Pathologies
Open call board member
The BELNUC Board hereby gives notice that the following BELNUC Board positions are open for election at the upcoming General Assembly, which will be held on March 6th 2021:
One board member 2021-2023 (physician or physicist)
We welcome all applications before February 5th 2021 online!
Winter School Dosimetry-Guided Treatment Planning for Radionuclide Therapy
January 20-22, 2021 (HS Maurice E. Müller, Inselspital, Bern, Switzerland)
This Dosimetry School targets medical physicists, physicians, technologists and researchers involved and interested in the workflow of clinical dosimetry in support to personalized radionuclide therapy.
Survey on the treatment of hypothyroidism
The Belgian Thyroid Club is conducting a short survey (+/- 10 min) on the treatment of hypothyroidism, in collaboration with the European Thyroid Association (ETA).
VIRTUAL ONLY: BELNUC Seminar – Radiopharmaceutical Radiobiology Advances in nuclear medicine : The future is now
Due to the new corona outbreak, the scheduled seminar on 14/11/2020 will be held as a live webinar only. There will be no in-person meeting! If you have previously registered for the seminar, you do not have to do anything and you will receive your login details over the next weeks.
Discover the program or register here.
How to become BELNUC member?
As we are working on our database infrastructure, the “Become BELNUC member”-button is temporarily out of action. However, we continue to welcome new members! See our Membership Application and Renewal page for more details: www.belnuc.be/belnuc-membership